Breaking News

IPS Appoints Compliance Manager

By Kristin Brooks | January 31, 2014

Corbin brings 23 years of experience

Scott Corbin has been appointed regional manager of Compliance for the New England region at IPS-Integrated Project Services, Inc. Mr. Corbin has more than 23 years of experience in the biotechnology, medical device and pharma industries, including experience in regulated environments across product development and operations within medical device and biopharma research and manufacturing facilities.
 
Mr. Corbin joins the company from Luitpold Pharmaceuticals, Inc., where managed technical quality operations. Previously, he held technical leadership positions with Genzyme, Lonza Biologics, and Glaxo/Wellcome. Mr. Corbin is an accredited ASQ Quality Auditor and ISO 13485 Certified Internal Auditor.
 
“With Scott’s depth of experience, including the manufacture and validation of biologics, medical devices and pharmaceutical products, we anticipate that he will deliver tangible, long-term value for our clients,” said Dave Goswami, PE, chief executive officer and chairman, IPS. “He has demonstrated leadership in delivering innovative and cost effective solutions in validation and quality assurance along with cutting-edge manufacturing and operations expertise. With the addition of Scott, IPS is well-positioned to help achieve strategic and business goals for companies located in New England.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important